TAKARA BIO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.55 EUR | +0.77% |
|
+5.65% | -14.94% |
| 05-10 | Takara Bio Inc. Proposes Dividend for the Fiscal Year Ending March 31, 2024, Effective June 24, 2024 | CI |
| 03-18 | Takara Bio Inc.(TSE:4974) dropped from FTSE All-World Index | CI |
Chart calendar Takara Bio Inc.
c22df9389fda07b1904319908c30.GyQuueY7keikm6GD73nLeZHNwWcgVzdYW_3vNBA9e0Q.T3Ba_N96zoHqwu3VghL-EqmU9DR0H38xNZ6OB3FoDRNLEWjohAyjuOao6A~0f8f7c3605553c117822e3912536213a
Upcoming events on Takara Bio Inc.
Past events on Takara Bio Inc.
| 2024-05-13 | Q4 2023 Earnings Call |
| 2024-05-09 | Q4 2023 Earnings Release |
| 2024-03-27 | Final dividend |
| 2024-02-13 | Q3 2023 Earnings Release |
| 2023-11-08 | Q2 2023 Earnings Release |
| 2023-08-07 | Q1 2023 Earnings Call |
| 2023-08-07 | Q1 2023 Earnings Release |
| 2023-05-15 | Q4 2022 Earnings Call |
| 2023-05-10 | Q4 2022 Earnings Release |
| 2023-03-29 | Détachement de for final dividend |
| 2023-02-08 | Q3 2022 Earnings Release |
| 2022-11-09 | Interim 2022 Earnings Release |
| 2022-08-03 | Q1 2022 Earnings Release |
| 2022-05-11 | FY 2021 Earnings Release |
| 2022-03-29 | Détachement de for final dividend |
| 2022-02-09 | Q3 2021 Earnings Release |
| 2021-11-08 | Interim 2022 Earnings Release |
| 2021-08-02 | Q1 2021 Earnings Release |
| 2021-05-12 | FY 2020 Earnings Release |
| 2021-03-29 | Détachement de for final dividend |
Past dividends on Takara Bio Inc.
| 2024-03-27 | Final Payment 17 JPY |
| 2023-03-29 | Final Payment 42 JPY |
| 2022-03-29 | Final Payment 33 JPY |
| 2021-03-29 | Final Payment 16 JPY |
| 2020-03-29 | Final Payment 8 JPY |
| 2019-03-26 | Final Payment 7 JPY |
| 2018-03-27 | Final Payment 4.5 JPY |
| 2017-03-28 | Final Payment 4 JPY |
| 2016-03-28 | Final Payment 1.8 JPY |
| 2015-03-26 | Final Payment 1.5 JPY |
Annual results
| Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 34 565 34 350 0.63% | 46 086 43 119 6.88% | 67 699 65 325 3.63% | 78 142 71 758 8.9% | 43 505 44 818 -2.93% | 47 412 |
|
EBITDA Million JPY | Released Forecast Spread | 9 691 9 300 4.2% | 17 658 15 707 12.42% | 32 956 31 973 3.08% | 25 190 24 537 2.66% | 7 922 7 329 8.09% | 9 403 |
|
EBIT Million JPY | Released Forecast Spread | 6 274 6 415 -2.19% | 13 952 11 148 25.16% | 28 902 27 270 5.98% | 20 541 20 131 2.04% | 3 003 2 939 2.19% | 5 070 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 5 433 6 150 -11.66% | 13 552 9 287 45.92% | 27 532 27 957 -1.52% | 21 224 20 046 5.88% | 2 853 2 962 -3.68% | 5 066 |
|
Net income Million JPY | Released Forecast Spread | 3 819 4 033 -5.29% | 9 547 7 262 31.47% | 19 849 19 157 3.61% | 16 012 14 128 13.33% | 1 480 2 058 -28.07% | 3 658 |
|
EPS JPY | Released Forecast Spread | 31,7 33,9 -6.45% | 79,3 60,3 31.49% | 165 159 3.63% | 133 117 13.31% | 12,3 17,1 -28.08% | 30,4 |
| Announcement Date | 14/05/20 | 13/05/21 | 12/05/22 | 11/05/23 | 10/05/24 | - |
Quarterly results
| Fiscal Period | March | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 18 115 17 870 1.37% | 17 393 17 400 -0.04% | 28 693 26 256 9.28% | 31 551 30 614 3.06% | 22 040 20 367 8.21% | 36 148 34 474 4.86% | 14 102 14 360 -1.8% | 18 485 17 269 7.04% | 32 587 33 318 -2.19% | 27 619 16 111 71.43% | 17 936 17 810 0.71% | 45 555 46 388 -1.8% | 9 176 11 900 -22.89% | 9 940 11 221 -11.42% | 19 116 20 368 -6.15% | 10 618 12 619 -15.85% | 13 771 14 043 -1.94% | 24 389 24 660 -1.1% | 9 594 | 10 274 | 19 868 | 11 323 | 15 231 | 26 553 |
|
EBIT Million JPY | Released Forecast Spread | 3 239 3 165 2.34% | 3 736 2 700 38.37% | 14 105 14 655 -3.75% | 8 976 8 136 10.32% | 14 797 13 957 6.02% | 4 537 5 556 -18.34% | 6 333 6 562 -3.49% | 10 870 12 670 -14.21% | 8 533 4 633 84.18% | 1 138 2 383 -52.25% | 9 671 9 448 2.36% | 423 2 100 -79.86% | 987 1 162 -15.06% | 1 410 1 585 -11.04% | -1 074 2 289 -146.92% | 2 667 2 045 30.42% | 1 593 971 64.06% | -175 | 819 | 644 | 913 | 2 586 | 3 499 | |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 2 483 3 100 -19.9% | 3 281 | 14 203 14 297 -0.66% | 7 418 7 950 -6.69% | 13 329 13 861 -3.84% | 5 479 5 194 5.5% | 6 352 8 078 -21.36% | 11 831 13 404 -11.74% | 8 487 3 870 119.3% | 906 639 41.78% | 9 393 9 126 2.93% | 505 2 150 -76.51% | 1 083 1 120 -3.3% | 1 588 1 625 -2.28% | -1 088 246 -542.28% | 2 353 1 681 39.98% | 1 265 593 113.32% | -259 | 734 | 475 | 822 | 2 519 | 3 341 | |
|
Net income Million JPY | Released Forecast Spread | 1 744 2 155 -19.07% | 2 274 1 600 42.13% | 10 009 9 989 0.2% | 5 485 5 871 -6.57% | 9 840 10 226 -3.77% | 3 907 3 667 6.54% | 4 631 6 045 -23.39% | 8 538 10 237 -16.6% | 6 057 2 563 136.32% | 1 417 245 478.37% | 7 474 6 302 18.6% | 319 1 540 -79.29% | 765 784 -2.42% | 1 084 1 103 -1.72% | -930 171 -643.86% | 1 326 1 376 -3.63% | 396 446 -11.21% | -539 | 454 | -85,0 | 542 | 2 239 | 2 781 | |
|
EPS JPY | Released Forecast Spread | 14,5 17,9 -19.05% | 18,9 | 83,1 83,0 0.14% | 45,6 48,8 -6.66% | 81,7 84,9 -3.75% | 32,5 30,5 6.39% | 38,5 50,3 -23.54% | 70,9 85,0 -16.58% | 50,3 21,3 136.15% | 11,8 2,00 488% | 62,1 52,3 18.66% | 2,65 13,0 -79.62% | 6,35 6,50 -2.31% | 9,00 9,20 -2.17% | -7,72 1,40 -651.43% | 11,0 11,4 -3.33% | 3,30 3,70 -10.81% | -4,50 | 3,80 | -0,70 | 4,50 | 18,6 | 23,1 | |
| Announcement Date | 14/05/20 | 10/11/20 | 13/05/21 | 09/11/21 | 12/05/22 | 12/05/22 | 04/08/22 | 10/11/22 | 10/11/22 | 09/02/23 | 11/05/23 | 11/05/23 | 08/08/23 | 09/11/23 | 09/11/23 | 14/02/24 | 10/05/24 | 10/05/24 | - | - | - | - | - | - |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 2024-07-22 07:00 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
| 2024-07-28 | CRISPR THERAPEUTICS AG: Q2 2024 Earnings Release (Projected) |
Past sector events for Takara Bio Inc.
| 2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-10 03:01 | SUNMAX BIOTECHNOLOGY CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-07-10 01:51 | POLARIS GROUP: June 2024 Sales and Revenue Release |
| 2024-06-11 03:04 | SUNMAX BIOTECHNOLOGY CO., LTD.: May 2024 Sales and Revenue Release |
| 2024-06-07 02:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 2024-05-29 16:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4974 Stock
- TF2 Stock
- Calendar Takara Bio Inc.
